Stocktoria
ROCKWELL MEDICAL, INC. RMTI
ROCKWELL MEDICAL, INC. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $69.3M | $101.5M | $83.6M | $72.8M | $61.9M | $62.2M | $61.3M | $63.4M | $57.3M | — |
| Gross profit | $11.7M | $17.5M | $8.7M | $4.1M | -$2.4M | $2.7M | $2.8M | -$1.6M | $3.7M | $6.8M |
| R&D expense | $0 | $19,000 | $1.1M | — | — | — | — | $5.6M | $6.3M | $5.8M |
| SG&A expense | — | — | — | — | — | — | — | $23.1M | $23.3M | $21.1M |
| Operating income | -$4.7M | $608,000 | -$6.7M | -$16.8M | -$30.3M | -$28.4M | -$34.5M | -$32.4M | -$25.9M | -$20.2M |
| Interest expense | — | — | $2.3M | $1.9M | $2.4M | $1.9M | $25,000 | — | — | — |
| Income tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $404,527 |
| Net income | -$5.3M | -$480,000 | -$8.4M | -$18.7M | -$32.7M | -$30.9M | -$34.1M | -$32.1M | -$25.9M | -$19.8M |
| EPS (diluted) | $-0.15 | $-0.03 | $-0.37 | $-1.31 | $-3.83 | $-0.41 | — | — | $-0.51 | $-0.39 |
| Operating cash flow | -$659,000 | $4.2M | -$9.4M | -$16.9M | -$33.5M | -$29.6M | -$27.3M | -$20.4M | -$21.1M | -$12.5M |
| Cash & equivalents | $10.7M | $15.7M | $9.0M | $10.1M | $13.3M | $48.7M | $11.8M | $22.7M | $8.4M | $17.2M |
| Inventory | $3.4M | $5.8M | $5.9M | $5.8M | $4.1M | $3.9M | $3.6M | $4.0M | $7.6M | $12.1M |
| Total assets | $57.1M | $59.2M | $52.2M | $46.6M | $48.6M | $77.7M | $44.3M | $52.6M | $58.8M | $83.2M |
| Total liabilities | $20.2M | $26.6M | $30.9M | $32.5M | $46.0M | $43.6M | $24.0M | $25.3M | $25.9M | — |
| Shareholders' equity | $37.0M | $32.6M | $21.3M | $14.1M | $2.5M | $34.2M | $20.3M | $27.3M | $32.9M | $53.0M |
Growth · year-over-year · Revenue CAGR 2.4%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | -31.8% | +21.4% | +14.8% | +17.6% | -0.4% | +1.5% | -3.3% | +10.6% | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.